Breaking NewsLaw.com and associated brands will be offline for scheduled maintenance Saturday May 8 3 AM US EST to 12 PM EST. We apologize for the inconvenience.

 
X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
U.S. District Judges Brian R. Martinotti of the District of New Jersey, left, and Wendy Beetlestone, right, of Eastern District of Pennsylvania (Courtesy photos) U.S. District Judges Brian R. Martinotti of the District of New Jersey, left, and Wendy Beetlestone, right, of the Eastern District of Pennsylvania (Courtesy photos)

Lawyers from several prominent firms are gearing up for a fight over which judge should oversee potentially hundreds of lawsuits filed over the pharmaceutical drug Elmiron.

About 80 lawsuits allege that Elmiron, used to treat a chronic bladder infection called interstitial cystitis, causes eye problems. Most cases are in either Pennsylvania or New Jersey, the headquarters of defendant Janssen Pharmaceuticals and its parent corporation, Johnson & Johnson.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

Amanda Bronstad

Amanda Bronstad is the ALM staff reporter covering class actions and mass torts nationwide. She writes the email dispatch Critical Mass. She is based in Los Angeles.

More from this author

 
Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.